Table 3. Selected Proteins That Are Likely to be Involved in the Pharmacodynamics and Pharmacokinetics (Metabolism, Distribution, Excretion, and Absorption) of the Selected Antihypertensive Drugsa.
| drug class | pharmacodynamic biological targets | pharmacokinetic
biological targets |
|||
|---|---|---|---|---|---|
| metabolism | distribution | excretion | absorption | ||
| thiazide and thiazide-like diuretics | solute carrier family 12 member 3 (NaCl symporter, NCC) | CYP3A4 | albumin | solute carrier family 22 member 6 (OAT1) | |
| microsomal epoxide hydrolase 1 | α1-acid glycoprotein 1 | ||||
| solute carrier family 12 member 1 (Na–Cl–K symporter, NKCC) | |||||
| calcium-activated potassium channel subunit α 1 (BK channel, BK) | |||||
| carbonic anhydrase 1/2/4 (CA1/2/4) | |||||
| calcium channel blockers | voltage-dependent L-type calcium channel subunit α1C (Cav1.2) | CYP3A4 | albumin | P-glycoprotein 1 (P-gP) | |
| CYP3A5 | |||||
| CYP2B6 | |||||
| CYP1A2 | |||||
| voltage-dependent T-type calcium channel subunit α1I (Cav3.3) | CYP2A6 | α1-acid glycoprotein | |||
| voltage-dependent L-type calcium channel subunit α1D (Cav3.3) | |||||
| voltage-dependent L-type calcium channel subunit β2 (Cav1.2b) | |||||
| ACE-I | angiotensin-converting enzyme (ACE) | albumin | solute carrier organic anion transporter family member 1A2 (OATP1) | solute carrier family 15-member 1 (PEPT1) | |
| renin | α1-acid glycoprotein | solute carrier family 15-member 2 (PEPT2) | |||
| ARBs | type 1 angiotensin II receptor (AT1) | CYP2C9 | albumin | solute carrier organic anion transporter family member 1B3 (OATP8) | |
| CYP3A4 | |||||
| UDP-glucuronosyl transferase 1-1 | |||||
| UDP-glucuronosyl transferase 1-3 | solute carrier organic anion transporter family member 1B1 (OATP2) | ||||
| UDP-glucuronosyl transferase 1-10 | |||||
| UDP-glucuronosyl transferase 2B7 | canalicular multispecific organic anion transporter 1 (MRP2) | ||||
| UDP-glucuronosyl transferase 2B17 | P-glycoprotein 1 (P-gp) | ||||
See Appendix I, Table S2 for a total overview.